Clinical Trial Update: Deanxit and Rivotril in Tinnitus Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports completion of a study evaluating Deanxit and Rivotril in patients with tinnitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• Deanxit (Flupentixol/Melitracen)
• Rivotril (clonazepam)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Tinnitus | Phase 4 | Status: COMPLETED